You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

LARGE

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoma, Non-Hodgkin, Diffuse Large B Cell Lymphoma Trial in Tianjin (CD19-targeted Chimeric Antigen Receptor(CAR) T Cells)

Recruiting
  • Lymphoma, Non-Hodgkin
  • Diffuse Large B Cell Lymphoma
  • CD19-targeted Chimeric Antigen Receptor(CAR) T Cells
  • Tianjin, Tianjin, China
    Tianjin Cancer Hospital
Nov 19, 2023

Exotropia, Evaluation of Surgical Techniques in Correcting Exotropia Trial (Evaluation of The Techniques of Lateral Rectus

Not yet recruiting
  • Exotropia
  • Evaluation of Surgical Techniques in Correcting Exotropia
  • Evaluation of The Techniques of Lateral Rectus Muscle Combined Recession with Hang Back and Combined Recession with Z-Tenotomy in Correcting Large-Angle Exotropia
  • (no location specified)
Oct 9, 2023

CNS Involvement in Primary Mediastinal Large B-Cell Lymphoma

Active, not recruiting
  • Primary Mediastinal Large B-cell Lymphoma (PMBCL)
  • DISEASE
  • (no location specified)
May 4, 2023

Large B-cell Lymphoma, DLBCL, Not Otherwise Specified, Primary Mediastinal Large B-cell Lymphoma (PMBCL) Trial (Epcoritamab)

Available
  • Large B-cell Lymphoma
  • +4 more
  • Epcoritamab
  • (no location specified)
Feb 16, 2023

Large Area Burns Trial in Chongqing (Stem cell preparation combined with Reticular skin, Stem cell preparation combined with

Not yet recruiting
  • Large Area Burns
  • Stem cell preparation combined with Reticular skin
  • +3 more
  • Chongqing, Chongqing, China
    Southwest Hospital, Army Medical University (Third Military Medi
Nov 2, 2023

Diffuse Large B-cell Lymphoma Trial (Rituximab, Mitoxantrone HCl liposome, Isophosphamide)

Not yet recruiting
  • Diffuse Large B-cell Lymphoma
  • (no location specified)
Mar 23, 2023

Large Cell Lymphoma, Diffuse, Relapsed Cancer, Refractory Cancer Trial (AutoSCT, GDP, Epcoritamab)

Not yet recruiting
  • Large Cell Lymphoma, Diffuse
  • +2 more
  • AutoSCT
  • +2 more
  • (no location specified)
May 10, 2023

Large B-cell Lymphoma Trial in Houston (Prednisone, Rituximab, Cyclophosphamide)

Not yet recruiting
  • Large B-cell Lymphoma
  • Houston, Texas
    M D Anderson Cancer Center
Sep 19, 2023

Primary Mediastinal Large B-cell Lymphoma (PMBCL), Primary Mediastinal Large B Cell Lymphoma, Primary Mediastinal Large B-Cell

Not yet recruiting
  • Primary Mediastinal Large B-cell Lymphoma (PMBCL)
  • +5 more
  • Boston, Massachusetts
  • +1 more
Jun 28, 2023

Triage of Acute Ischemic Stroke Due to Large Vessel Occlusions-1

Completed
  • Stroke, Acute Ischemic
  • +2 more
  • Endovascular Therapy
  • Tianjin, Tianjin, China
    Tianjin Huanhu Hospital
May 23, 2023

Diffuse Large B-cell Lymphoma Trial in Changchun (Mitoxantrone HCl liposome injection, RiTUXimab Injection, Cyclophosphamid)

Not yet recruiting
  • Diffuse Large B-cell Lymphoma
  • Mitoxantrone hydrochloride liposome injection
  • +4 more
  • Changchun, Jilin, China
    The First Bethune Hospital of Jilin University
Aug 15, 2023

Recurrent B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between DLBCL and Classic Hodgkin Lymphoma, Recurrent

Not yet recruiting
  • Recurrent B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma
  • +21 more
  • Biopsy
  • +8 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Apr 7, 2023

Chidamide in Recurrent and Refractory Diffuse Large b

Enrolling by invitation
  • Diffuse Large B-cell Lymphoma
  • Suzhou, Jiangsu, China
    Second Affiliated Hospital of Soochow University
Jan 9, 2023

Frontline of ASCT in High-risk DLBCL

Recruiting
  • Diffuse Large B Cell Lymphoma
    • Beijing, Beijing, China
      Peking University People's Hospital
    Apr 26, 2023

    Ischemic Stroke Trial in Kafr Ash Shaykh (Ticagrelor 90 MG, Clopidogrel)

    Recruiting
    • Ischemic Stroke
    • Kafr Ash Shaykh, Egypt
      Kafr Elsheikh University Hospital
    Nov 7, 2023

    Myopia, Severe Trial (Structural and fonctional phynotyping)

    Not yet recruiting
    • Myopia, Severe
    • Structural and fonctional phynotyping
    • (no location specified)
    Apr 28, 2023

    Relmacabtagene Autoleucel in Patients With LBCL

    Recruiting
    • Large B-cell Lymphoma
    • Relmacabtagene Autoleucel
    • Shanghai, Shanghai, China
      Ruijin Hospital Affiliated to Shanghai Jiao Tong University Scho
    Nov 15, 2023

    Acute Ischemic Stroke, Mild Neurocognitive Disorder, Thrombectomy Trial (Endovascular therapy, Best medical management)

    Not yet recruiting
    • Acute Ischemic Stroke
    • +2 more
    • Endovascular therapy
    • Best medical management
    • (no location specified)
    Nov 21, 2023

    Autologous Epidermal Cell Transplantation Trial (Cultured autologous epidermal cell membrane)

    Not yet recruiting
    • Autologous Epidermal Cell Transplantation
    • Cultured autologous epidermal cell membrane
    • (no location specified)
    May 31, 2023

    Diffuse Large B-cell Lymphoma and High-grade B-cell Lymphoma

    Not yet recruiting
    • Lymphoma, B-Cell
    • +6 more
    • Plasma metabolomic profile by Ultra-high performance liquid chromatography with quadrupole time-of-flight mass spectrometry (UPLC-QTOFMS)
    • Guayaquil, Guayas, Ecuador
      Instituto Oncológico Nacional Dr. Juan Tanca Marengo
    Apr 27, 2023

    DLBCL - Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial in Xiamen (Lenalidomide combined with G-CHOP (LO CHOP))

    Recruiting
    • DLBCL - Diffuse Large B Cell Lymphoma
    • Follicular Lymphoma
    • Lenalidomide combined with G-CHOP (LO CHOP)
    • Xiamen, Fujian, China
      Bing Xu
    Nov 28, 2023

    Relapsed/Refractory Diffuse Large B Cell Lymphoma Trial in Seoul (Glofitamab, Poseltinib, Lenalidomide)

    Recruiting
    • Relapsed/Refractory Diffuse Large B Cell Lymphoma
    • Glofitamab, Poseltinib, Lenalidomide
    • Seoul, Korea, Republic of
      Seoul National University Hospital
    Nov 28, 2022

    Living Conditions of Diffuse Large B-Cell Lymphoma or Follicular

    Completed
    • Diffuse Large Cell Diffuse Lymphoma
    • Follicular Lymphoma
    • Questionnaires
    • Collection of clinical data and treatments
    • Dijon, France
      Chu Dijon Bourogne
    Jan 31, 2023

    Large B-cell Lymphoma, Diffuse Large B Cell Lymphoma Trial in Homburg (R-miniCHOP + Acalabrutinib, R-miniCHOP)

    Not yet recruiting
    • Large B-cell Lymphoma
    • Diffuse Large B Cell Lymphoma
    • Homburg, Saarland, Germany
      Saarland University Medical Center
    Apr 19, 2023

    DLBCL Trial (maplirpacept (PF-07901801), Glofitamab, Obinutuzumab)

    Not yet recruiting
    • Diffuse Large B-Cell Lymphoma
    • maplirpacept (PF-07901801)
    • +2 more
    • (no location specified)
    May 30, 2023